| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 918 | 2021 |
| Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial M Rosenzwajg, R Lorenzon, P Cacoub, HP Pham, F Pitoiset, K El Soufi, ... Annals of the rheumatic diseases 78 (2), 209-217, 2019 | 366 | 2019 |
| Autoimmune haemolytic anaemia associated with COVID‐19 infection G Lazarian, A Quinquenel, M Bellal, J Siavellis, C Jacquy, D Re, ... British journal of haematology 190 (1), 29, 2020 | 338 | 2020 |
| Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis M Soussan, P Nicolas, C Schramm, S Katsahian, G Pop, O Fain, ... Medicine 94 (14), e622, 2015 | 318 | 2015 |
| Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19 T Hueso, C Pouderoux, H Péré, AL Beaumont, LA Raillon, F Ader, ... Blood, The Journal of the American Society of Hematology 136 (20), 2290-2295, 2020 | 295 | 2020 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 291 | 2021 |
| Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris B Duchemann, I Annesi-Maesano, CJ de Naurois, S Sanyal, PY Brillet, ... European Respiratory Journal 50 (2), 2017 | 291 | 2017 |
| COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study J Avouac, E Drumez, E Hachulla, R Seror, S Georgin-Lavialle, ... The Lancet Rheumatology 3 (6), e419-e426, 2021 | 262 | 2021 |
| Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients S Georgin‐Lavialle, B Terrier, AF Guedon, M Heiblig, T Comont, E Lazaro, ... British Journal of Dermatology 186 (3), 564-574, 2022 | 261 | 2022 |
| Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review J Alijotas-Reig, E Esteve-Valverde, C Belizna, A Selva-O'Callaghan, ... Autoimmunity reviews 19 (7), 102569, 2020 | 245 | 2020 |
| Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study A Mekinian, E Grignano, T Braun, O Decaux, E Liozon, ... Rheumatology 55 (2), 291-300, 2016 | 232 | 2016 |
| Kikuchi-Fujimoto disease: retrospective study of 91 cases and review of the literature G Dumas, V Prendki, J Haroche, Z Amoura, P Cacoub, L Galicier, ... Medicine 93 (24), 372-382, 2014 | 223 | 2014 |
| Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients C Comarmond, L Biard, M Lambert, A Mekinian, Y Ferfar, JE Kahn, ... Circulation 136 (12), 1114-1122, 2017 | 214 | 2017 |
| Efficacy of biological-targeted treatments in Takayasu arteritis: multicenter, retrospective study of 49 patients A Mekinian, C Comarmond, M Resche-Rigon, T Mirault, JE Kahn, ... Circulation 132 (18), 1693-1700, 2015 | 206 | 2015 |
| Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): characteristics, treatment and outcome in 251 cases from the literature C Laurent, J Capron, B Quillerou, G Thomas, S Alamowitch, O Fain, ... Autoimmunity reviews 15 (12), 1129-1133, 2016 | 198 | 2016 |
| The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study A Mekinian, MG Lazzaroni, A Kuzenko, J Alijotas-Reig, A Ruffatti, P Levy, ... Autoimmunity reviews 14 (6), 498-502, 2015 | 193 | 2015 |
| Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre … S Le Burel, S Champiat, C Mateus, A Marabelle, JM Michot, C Robert, ... European Journal of Cancer 82, 34-44, 2017 | 187 | 2017 |
| Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature MR Pokeerbux, J Giovannelli, L Dauchet, L Mouthon, C Agard, JC Lega, ... Arthritis research & therapy 21, 1-12, 2019 | 182 | 2019 |
| Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases Y Allenbach, Y Uzunhan, S Toquet, G Leroux, L Gallay, A Marquet, ... Neurology 95 (1), e70-e78, 2020 | 180 | 2020 |
| Unexplained recurrent miscarriage and recurrent implantation failure: is there a place for immunomodulation? A Mekinian, J Cohen, J Alijotas‐Reig, L Carbillon, P Nicaise‐Roland, ... American Journal of Reproductive Immunology 76 (1), 8-28, 2016 | 179 | 2016 |
Angela TincaniReumatologia e Immunologia Clinica ERN ReCONNET - ASST Spedali Civili and University of Brescia在 unibs.it 的电子邮件经过验证
